Thiolation of polymers is one of the most appropriate approaches to impart higher mechanical strength and mucoadhesion. Thiol modification of gum karaya and gum acacia was carried out by esterification with 80% thioglycolic acid. FTIR, DSC and XRD confirmed the completion of thiolation reaction. Anticancer potential of developed thiomer was studied on cervical cancer cell lines (HeLa) and more than 60% of human cervical cell lines (HeLa) were inhibited at concentration of 5 µg/100 µL. Immobilized thiol groups were found to be 0.8511 mmol/g as determined by Ellman’s method. Cytotoxicity studies on L929 fibroblast cell lines indicated thiomers were biocompatible. Bilayered tablets were prepared using Ivabradine hydrochloride as the model drug and synthesized thiolated gums as mucoadhesive polymer. Tablets prepared using thiolated polymers in combination showed more swelling, mucoadhesion and residence time as compared to unmodified gums. Thiol modification controlled the release of the drug for 24 h and enhanced permeation of the drug up to 3 fold through porcine buccal mucosa as compared to tablets with unmodified gums. Thiolated polymer showed increased mucoadhesion and permeation, anticancer potential, controlled release and thus can be utilized as a novel excipient in formulation development.
Background and objectives: Increase in the cellular oxidative stress level of a host invites many dreadful diseases and even causes cancer. In this study, the hematological, histopathological and enzymatic analysis was evaluated in Lactobacillus plantarum (LAC), Dimethylhydrazine (DMH) and capecitabine (CAP) treated Wistar rat models. Materials and Methods: The LAC was cultured in a natural media of pasteurized milk. The study was conducted on Wistar rats (n=24), where four groups were assigned: normal vehicle control (n=6), DMH group (n=6), LAC + DMH group (n=6) and CAP + DMH group (n=6). The chemical oxidative stress enhancer which induces colon cancer was introduced by subcutaneous route in all Wistar rats group except normal vehicle control. The cultured LAC was given by per-oral route to LAC + DMH group after 24 h of DMH induction. Capecitabine a synthetic standard drug showing antioxidant activity was given in CAP + DMH group after 24 h of DMH induction. After six weeks study the blood was collected for haematological evaluation and animals were sacrificed as per the ethical committee guidelines. Histopathological analysis of the colonic part along with the enzyme analysis was carried out in all animal groups. Results: Hematological studies proved that the LAC reduce the oxidative stress; which includes an increase in haemoglobin level and static white blood cell count compared to the DMH group and capecitabine. Enzyme studies proved that LAC treated group shows significantly (p < 0.05) less colonic nitrate content as compared to the capecitabine-treated group. Further, the LAC treated group did not show any changes in liver and spleen index parameters, indicating that liver and spleen functioning of the host is not altered or triggered the immunological aspects. Histopathological studies demonstrated that LAC treated group shows significantly (p < 0.05) less hyperplasia and aberrant foci condition as compared to other treated groups. It was concluded that LAC proved to be a more effective antioxidant than synthetic drug capecitabine against DMH colon cancer inducer.